VASO Corp (ticker: VASO) is an OTC-listed electromedical & electrotherapeutic apparatus company. DredgeCap's structured extraction of VASO's SEC filings surfaces 10 active risk signals, including 9 late-filing signals, and 1 auditor-change signal. VASO reported $89.10M in revenue and $1.57M for the period ending 2025-12-31, with operating cash flow of $9.27M. Cash and equivalents stood at $35.05M (up 33.4% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
VASO SEC Filings
Full cached SEC EDGAR filing history for VASO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.